Dynamic 14-day Platelet Count Predicts 28-day Mortality in Sepsis: A Single-Center Retrospective Cohort Study
Clinical and Applied Thrombosis/Hemostasis · 2026-01 · 32
DOI: 10.1177/10760296261422759 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, online erschienen am 03.03.2026. Verfasst von Rui Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, China. Hauptthemen laut MEDLINE: Sepsis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Changzhou Sci & Tech Program., Technology Project of Changzhou Municipal Health Commission, Science and Technology Projects of Changzhou City.
Themen: Sepsis
Abstract (Originalsprache)
Background
Thrombocytopenia is the most frequent hemostatic abnormality in sepsis and is closely linked to excess mortality.
Methods
We undertook a retrospective cohort study of 82 septic patients admitted to Changzhou Second People's Hospital between 1 January 2023 and 30 June 2024. Participants were stratified by 28-day survival status. The clinical differences, platelet trends, prognostic value, and risk-factor analysis were analyzed between the two groups.
Results
Survivors and non-survivors differed significantly in age, oxygenation index, white-blood-cell count, serum albumin, cholinesterase and in the prevalence of diabetes and hypertension (all comparisons P < .05). Platelet counts measured on intensive care unit (ICU) days 1, 3, 7 and 14 were assessed for their prognostic value. By day 14, platelet counts were markedly higher in survivors than in non-survivors ( P < .05). The day-14 platelet count yielded an area under the receiver-operating-characteristic (ROC) curve (AUC) of 0.640, outperforming the day-1 platelet count (AUC 0.514), APACHE II score (AUC 0.488) and Sequential Organ Failure Assessment (SOFA) score (AUC 0.394; all comparisons P < .05). Kaplan–Meier analysis showed that patients whose day-14 platelet count was ≥ 224 × 10 9 L −1 had significantly better 28-day survival than those below this threshold ( P < .05). Platelet count < 224 × 10 9 L − 1 in day 14 was an independent predictor of 28-day mortality ( P < .05).
Conclusion
The survival group shares high platelet count and maintaining platelet count at a higher level is associated with improving the 28-day prognosis of sepsis patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, China.
ORCID-Profile: Rui Zhang
Förderung
- Changzhou Sci & Tech Program.
- Technology Project of Changzhou Municipal Health Commission
- Science and Technology Projects of Changzhou City
Zitieren
APA
Zhang, R., Kong, F., Han, W., Shi, D., Zhao, G., Zhou, Y., & Xu, T. (2026). Dynamic 14-day Platelet Count Predicts 28-day Mortality in Sepsis: A Single-Center Retrospective Cohort Study. Clinical and Applied Thrombosis/Hemostasis, 32. https://doi.org/10.1177/10760296261422759
Vancouver
Zhang R, Kong F, Han W, Shi D, Zhao G, Zhou Y, et al. Dynamic 14-day Platelet Count Predicts 28-day Mortality in Sepsis: A Single-Center Retrospective Cohort Study. Clinical and Applied Thrombosis/Hemostasis. 2026;32. doi:10.1177/10760296261422759
BibTeX
@article{Zhang2026,
author = {Zhang, Rui and Kong, Fanfeng and Han, Wenmin and Shi, Dongwei and Zhao, Gang and Zhou, Yi and Xu, Tongrong},
title = {Dynamic 14-day Platelet Count Predicts 28-day Mortality in Sepsis: A Single-Center Retrospective Cohort Study},
journal = {Clinical and Applied Thrombosis/Hemostasis},
year = {2026},
volume = {32},
doi = {10.1177/10760296261422759}
}
EUVIMED